Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)-Reference-Cited by-同舟云学术

Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)

Published:2013-06-06 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ziganshina Lilia E¹,Titarenko Albina F¹,Davies Geraint R²

Affiliation:

1. Kazan (Volga region) Federal University; Department of Basic and Clinical Pharmacology; 18 Kremlevskaya Street, 420008 14-15 Malaya Krasnaya Street, 420015 Kazan Tatarstan Russian Federation

2. University of Liverpool; Institute of Infection and Global Health; Apex Building 8 West Derby Street Liverpool Merseyside UK L69 7BE

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004795.pub4/fullpdf

Reference119 articles.

1. Moxifloxacin versus ethambutol in the first two months of treatment for pulmonary tuberculosis;Burman;American Journal of Respiratory and Critical Care Medicine,2006

2. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial;Conde;Lancet,2009

3. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis;Dorman;American Journal of Respiratory and Critical Care Medicine,2009

4. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG);El-Sadr;Clinical Infectious Diseases,1998

5. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis;Rustomjee;International Journal of Tuberculosis and Lung Disease,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory fluoroquinolones in the treatment of specific and non-specific lung diseases (literature review);Vrach;2024-02-02

2. Augmentation of the Clinical Efficacy of Levofloxacin and Antituberculosis Drugs by Chinese Herbal Preparations in Pulmonary Tuberculosis;CURRENT TOPICS IN NUTRACEUTICAL RESEARCH;2023-10-09

3. Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery;Archiv der Pharmazie;2022-07-15

4. Levofloxacin Use in Patients with Suspected Tuberculosis in a Community Hospital, Thailand: A Pilot Study;Advances in Pharmacological and Pharmaceutical Sciences;2022-06-03

5. Efficacy and safety of daily treatments for drug-susceptible pulmonary tuberculosis: a systematic review and network meta-analysis;Journal of Pharmacy and Pharmacology;2022-03-30